Abiraterone acetate is a potent selective, orally active inhibitor of the key enzyme in testosterone synthesis, 17a-hydroxylase-C17,20-lyase. Patent application was filed on 18-08-2011 as a divisional application to the application mentioned under INID code 62.
Abiraterone acetate is a potent selective, orally active inhibitor of the key enzyme in testosterone synthesis, 17a-hydroxylase-C17,20-lyase. Patent application was filed on 18-08-2011 as a divisional application to the application mentioned under INID code 62.
Abiraterone acetate is a potent selective, orally active inhibitor of the key enzyme in testosterone synthesis, 17a-hydroxylase-C17,20-lyase. Patent application was filed on 18-08-2011 as a divisional application to the application mentioned under INID code 62.